Inhibition of the vascular endothelial cell (VE)-specific adhesion molecule VE-cadherin blocks gonadotropin-dependent folliculogenesis and corpus luteum formation and angiogenesis

Endocrinology

Volumn 146, Issue 3, 2005, Pages 1053-1059

  Nakhuda, Gary S ^a   Zimmermann, Ralf C ^a,c   Bohlen, Peter ^b   Liao, Fang ^b   Sauer, Mark V ^a   Kitajewski, Jan ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b ELI LILLY AND COMPANY   (United States)

^c College of Physicians and Surgeons ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN; ESTRADIOL; PROGESTERONE; SERIC GONADOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHEMOLUMINESCENCE; CONTROLLED STUDY; CORPUS LUTEUM; ESTRADIOL BLOOD LEVEL; FEMALE; HISTOLOGY; IMMUNOASSAY; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; OVARY FOLLICLE; OVARY FOLLICLE DEVELOPMENT; OVULATION INDUCTION; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD31; CADHERINS; CELL ADHESION; CORPUS LUTEUM; ENDOTHELIAL CELLS; FEMALE; GONADOTROPINS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; MALE; MICE; NEOVASCULARIZATION, PATHOLOGIC; ORGAN SIZE; OVARIAN FOLLICLE; OVARY; PREGNANCY; PREGNANCY, ANIMAL; TIME FACTORS; UTERUS; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 14244250418     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2004-0977     Document Type: Article

References (34)

1. Neeman M, Abramovitch R, Schiffenbauer YS, Tempel C 1997 Regulation of angiogenesis by hypoxic stress: from solid tumours to the ovarian follicle. Int J Exp Pathol 78:57-70
2. Gomez R, Simon C, Remohi J, Pellicer A 2003 Administration of moderate and high doses of gonadotropins to female rats increases ovarian vascular endothelial growth factor (VEGF) and VEGF receptor-2 expression that is associated to vascular hyperpermeability. Biol Reprod 68:2164-2171
3. Wulff C, Wiegand SJ, Saunders PT, Scobie GA, Fraser HM 2001 Angiogenesis during follicular development in the primate and its inhibition by treatment with truncated Flt-1-Fc (vascular endothelial growth factor Trap(A40)). Endocrinology 142:3244-3254
4. Wulff C, Wilson H, Rudge JS, Wiegand SJ, Lunn SF, Fraser HM 2001 Luteal angiogenesis: prevention and intervention by treatment with vascular endothelial growth factor trap(A40). J Clin Endocrinol Metab 86:3377-3386
5. Zimmermann RC, Hartman T, Bohlen P, Sauer MV, Kitajewski J 2001 Preovulatory treatment of mice with anti-VEGF receptor 2 antibody inhibits angiogenesis in corpora lutea. Microvasc Res 62:15-25
6. Zimmermann RC, Xiao E, Bohlen P, Ferin M 2002 Administration of anti-vascular endothelial growth factor receptor 2 antibody in the early follicular phase delays follicular selection and development in the rhesus monkey. Endocrinology 143:2496-2502
7. Zimmermann RC, Hartman T, Kavic S, Pauli SA, Bohlen P, Sauer MV, Kitajewski J 2003 Vascular endothelial growth factor receptor 2-mediated angiogenesis is essential for gonadotropin-dependent follicle development. J Clin Invest 112:659-669
8. Aberle H, Schwartz H, Kemler R 1996 Cadherin-catenin complex: protein interactions and their implications for cadherin function. J Cell Biochem 61:514-523
9. Shapiro L, Fannon AM, Kwong PD, Thompson A, Lehmann MS, Grubel G, Legrand JF, Als-Nielsen J, Colman DR, Hendrickson WA 1995 Structural basis of cell-cell adhesion by cadherins. Nature 374:327-337
10. Navarro P, Caveda L, Breviario F, Mandoteanu I, Lampugnani MG, Dejana E 1995 Catenin-dependent and -independent functions of vascular endothelial cadherin. J Biol Chem 270:30965-30972
11. Miller JR, Moon RT 1996 Signal transduction through β-catenin and specification of cell fate during embryogenesis. Genes Dev 10:2527-2539
12. Vittet D, Buchou T, Schweitzer A, Dejana E, Huber P 1997 Targeted null-mutation in the vascular endothelial-cadherin gene impairs the organization of vascular-like structures in embryoid bodies. Proc Natl Acad Sci USA 94:6273-6278
13. Liao F, Doody JF, Overholser J, Finnerty B, Bassi R, Wu Y, Dejana E, Kussie P, Bohlen P, Hicklin DJ 2002 Selective targeting of angiogenic tumor vasculature by vascular endothelial-cadherin antibody inhibits tumor growth without affecting vascular permeability. Cancer Res 62:2567-2575
14. Lampugnani MG, Dejana E 1997 Interendothelial junctions: structure, signalling and functional roles. Curr Opin Cell Biol 9:674-682
15. Corada M, Zanetta L, Orsenigo F, Breviario F, Lampugnani MG, Bernasconi S, Liao F, Hicklin DJ, Bohlen P, Dejana E 2002 A monoclonal antibody to vascular endothelial-cadherin inhibits tumor angiogenesis without side effects on endothelial permeability. Blood 100:905-911
16. Wang XN, Greenwald GS 1993 Hypophysectomy of the cyclic mouse. I. Effects on folliculogenesis, oocyte growth, and follicle-stimulating hormone and human chorionic gonadotropin receptors. Biol Reprod 48:585-594
17. Halpin DM, Charlton HM 1988 Effects of short-term injection of gonadotrophins on ovarian follicle development in hypogonadal (hpg) mice. J Reprod Fertil 82:393-400
18. Wang XN, Greenwald GS 1993 Hypophysectomy of the cyclic mouse. II. Effects of follicle-stimulating hormone (FSH) and luteinizing hormone on folliculogenesis, FSH and human chorionic gonadotropin receptors, and steroidogenesis. Biol Reprod 48:595-605
19. Pedersen T, Peters H 1968 Proposal for a classification of oocytes and follicles in the mouse ovary. J Reprod Fertil 17:555-557
20. Geva E, Jaffe RB 2000 Role of vascular endothelial growth factor in ovarian physiology and pathology. Fertil Steril 74:429-438
21. Rowe AJ, Morris KD, Bicknell R, Fraser HM 2002 Angiogenesis in the corpus luteum of early pregnancy in the marmoset and the effects of vascular endothelial growth factor immunoneutralization on establishment of pregnancy. Biol Reprod 67:1180-1188
22. Arfuso F, Meyer GT 2003 Apoptosis does not affect the vasculature of the corpus luteum of pregnancy in the rat. Apoptosis 8:665-671
23. Rabbani ML, Rogers PA 2001 Role of vascular endothelial growth factor in endometrial vascular events before implantation in rats. Reproduction 122:85-90
24. Rockwell LC, Pillai S, Olson CE, Koos RD 2002 Inhibition of vascular endothelial growth factor/vascular permeability factor action blocks estrogen-induced uterine edema and implantation in rodents. Biol Reprod 67:1804-1810
25. Calera MR, Venkatakrishnan A, Kazlauskas A 2004 VE-cadherin increases the half-life of VEGF receptor 2. Exp Cell Res 300:248-256
26. Carmeliet P, Collen D 200 Molecular basis of angiogenesis: role of VEGF and VE-cadherin. Ann NY Acad Sci 902:249-262
27. Folkman J, Shing Y 1992 Angiogenesis. J Biol Chem 267:10931-10934
28. Folkman J 1995 Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis. N Engl J Med 333:1757-1763
29. Auerbach W, Auerbach R 1994 Angiogenesis inhibition: a review. Pharmacol Ther 63:265-311
30. Fraser HM, Lunn SF 2000 Angiogenesis and its control in the female reproductive system. Br Med Bull 56:787-797
31. Gordon JD, Mesiano S, Zaloudek CJ, Jaffe RB 1996 Vascular endothelial growth factor localization in human ovary and fallopian tubes: possible role in reproductive function and ovarian cyst formation. J Clin Endocrinol Metab 81:353-359
32. Ferrara N, Frantz G, LeCouter J, Dillard-Telm L, Pham T, Draksharapu A, Giordano T, Peale F 2003 Differential expression of the angiogenic factor genes vascular endothelial growth factor (VEGF) and endocrine gland-derived VEGF in normal and polycystic human ovaries. Am J Pathol 162:1881-1893
33. Sonmezer M, Gungor M, Ensari A, Orlac F 2004 Prognostic significance of tumor angiogenesis in epithelial ovarian cancer: in association with transforming growth factor β and vascular endothelial growth factor. Int J Gynecol Cancer 14:82-88
34. Pauli SA, Tang H, Wang J, Bohlen P, Posser R, Hartman T, Sauer MV, Kitajewski J, Zimmermann RC 9 December 2004 The VEGF/VEGF receptor 2 pathway is critical for blood vessel survival in corpora lutea of pregnancy in the rodent. Endocrinology 10.1210/en.2004-0765 1060-1065